Actinium Pharmaceuticals files initial beneficial ownership statement for CFO Matthew T. David
ATNM•Actinium Pharmaceuticals CFO Matthew T. David signed an initial statement of beneficial ownership on Oct. 16, 2026.
ATNM•ATNM•ATNM•Actinium Pharmaceuticals CFO Matthew T. David signed an initial statement of beneficial ownership on Oct. 16, 2026.
Chief Financial Officer Matthew T. David signed an initial statement of beneficial ownership on Oct. 16, 2026.
